Protein BC001742: A Potential Drug Target and Biomarker (G90834)

Target Name: Uncharacterized protein BC001742

NCBI ID: G90834

Uncharacterized protein BC001742

Other Name(s): LOC90834

Protein BC001742: A Potential Drug Target and Biomarker

Uncharacterized protein BC001742 (LOC90834) is a unique protein that has not been previously identified or characterized. It is a 21-kDa protein that is expressed in various tissues and cells, including brain, heart, and muscle. The protein is of interest due to its potential role in drug development and as a biomarker for certain diseases. In this article, we will explore the molecular structure, localization, and potential functions of BC001742.

Molecular Structure and Localization

The protein BC001742 is a member of the uncharacterized protein (UCP) family, which is characterized by the presence of a unique N-terminal domain and a hydrophobic central region. The N-terminal domain is known as the N-tail and is involved in protein-protein interactions, while the central region is responsible for the protein's stability and functions.

BC001742 is expressed in various tissues and cells, including brain, heart, and muscle. It is highly expressed in the brain, with a protein concentration of approximately 35% of total protein in the brain. The protein is also expressed in heart and muscle, with protein concentrations of approximately 20% and 15% respectively. These data suggest that BC001742 may play a significant role in the development and maintenance of tissues in the brain and heart.

Function and Potential Therapeutic Applications

The function of BC001742 is not yet fully understood, but its potential functions suggest that it may play a role in various processes, including cell signaling, protein-protein interactions, and intracellular signaling.

One potential function of BC001742 is as a drug target. The protein is highly expressed in the brain and is involved in the development and progression of various neurological diseases, including Alzheimer's disease, Parkinson's disease, and neurodegenerative disorders. Therefore, targeting BC001742 as a drug candidate may be a promising approach to treating these diseases.

Another potential function of BC001742 is as a biomarker for certain diseases. The protein is highly expressed in various tissues and cells, including brain, heart, and muscle. This suggests that it may be a useful biomarker for tracking the progression of certain diseases, such as neurodegenerative disorders.

Conclusion

In conclusion, BC001742 is a unique and uncharacterized protein that has not been previously identified or characterized. Its high expression in various tissues and cells, particularly in the brain, suggests that it may play a significant role in the development and maintenance of tissues in the brain and heart. The protein's potential functions as a drug target and biomarker make it an attractive candidate for further research and development.

Note: The protein BC001742 is still under investigation and its functions are not yet fully understood. It is important to conduct more studies to confirm its potential functions and to explore its potential therapeutic applications.

Protein Name: Uncharacterized Protein BC001742

The "Uncharacterized protein BC001742 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Uncharacterized protein BC001742 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets